|
End-of-day quote
Shenzhen S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 8.470 CNY | +0.47% |
|
-6.10% | +6.68% |
| 26/08 | Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026 | CI |
| 24/08 | Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 492.69Cr 73Cr 63Cr 59Cr 54Cr 101.53Cr 6.93TCr 101.81Cr 702.09Cr 272.44Cr 3.56TCr 275.58Cr 269.57Cr 11TCr | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 475.81Cr 71Cr 61Cr 57Cr 52Cr 98Cr 6.69TCr 98Cr 678.03Cr 263.11Cr 3.43TCr 266.13Cr 260.33Cr 11TCr | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +0.47% | ||
| 1 week | -6.10% | ||
| Current month | -2.87% | ||
| 1 month | +5.48% | ||
| 3 months | +6.68% | ||
| 6 months | -16.22% | ||
| Current year | +6.68% |
| 1 week | 8.36 |  | 8.95 |
| 1 month | 7.9 | | 10.72 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -6.10% | -18.24% | +33.39% | 73Cr | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,02400Cr | |
| -1.15% | +2.68% | +54.25% | +71.29% | 66TCr | |
| -1.44% | +0.38% | +20.65% | +75.54% | 45TCr | |
| +0.14% | -0.47% | +30.20% | +40.61% | 35TCr | |
| -1.33% | +4.72% | +24.62% | +47.60% | 30TCr | |
| -1.15% | +0.30% | -0.69% | +11.83% | 25TCr | |
| -1.55% | +1.11% | +54.15% | +72.13% | 24TCr | |
| -0.88% | +1.15% | -14.60% | -54.84% | 21TCr | |
| -0.15% | +3.65% | +31.24% | +100.90% | 19TCr | |
| Average | -0.79% | +0.70% | +23.96% | +50.44% | 36.79TCr | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.62% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 98Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.38TCr 20Cr 140.16Cr 54Cr 709.68Cr 55Cr 54Cr 2.29TCr | 120.53Cr 18Cr 15Cr 15Cr 13Cr 25Cr 1.7TCr 25Cr 171.75Cr 67Cr 869.66Cr 67Cr 66Cr 2.8TCr |
| Net income | 1.37Cr 20.33L 17.5L 16.46L 15.04L 28.13L 19Cr 28.21L 1.95Cr 75.49L 9.85Cr 76.36L 74.69L 32Cr | 9.27Cr 1.38Cr 1.19Cr 1.12Cr 1.02Cr 1.91Cr 130.42Cr 1.92Cr 13Cr 5.13Cr 67Cr 5.19Cr 5.07Cr 215.56Cr |
| Net Debt | 19Cr 2.82Cr 2.42Cr 2.28Cr 2.08Cr 3.9Cr 265.92Cr 3.91Cr 27Cr 10Cr 136.43Cr 11Cr 10Cr 439.53Cr | -17Cr -2.51Cr -2.16Cr -2.04Cr -1.86Cr -3.48Cr -237.41Cr -3.49Cr -24Cr -9.33Cr -121.81Cr -9.44Cr -9.24Cr -392.4Cr |
Employees
1,188
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | CN¥8.470 | +0.47% | 2,57,54,897 |
| 03/26/03 | CN¥8.430 | -1.98% | 2,46,62,175 |
| 02/26/02 | CN¥8.600 | -1.83% | 2,69,98,992 |
| 01/26/01 | CN¥8.760 | +0.46% | 3,22,48,025 |
| 31/26/31 | CN¥8.720 | -3.33% | 3,62,01,250 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
